SCHD’s ten biggest holdings now account for 41% of the fund, concentrating roughly $164,000 of a $400,000 position into ten names and exposing shareholders to a heavier single-stock and sector load than the ETF’s 100-stock label suggests.
The top 10 positions carry individual weights of around 3% each, with Qualcomm the largest holding and names such as Texas Instruments, UnitedHealth, Chevron, Coca‑Cola, ConocoPhillips, Verizon and Amgen among the list. SCHD manages about $94 billion, tracks the Dow Jones U.S. Dividend 100 Index, offers a 3.27% yield and charges a 0.06% expense ratio.
Performance has been mixed versus a plain-vanilla S&P 500 ETF. Over the past year SCHD returned 29% while SPY returned 27%. Over five years SCHD returned 50% compared with SPY’s 79%. Over ten years SCHD returned 233% and SPY 258%. By contrast, VYM—which holds roughly 620 names and a top-10 concentration near 24%—returned 69% over five years. Another dividend-tilted ETF, DGRO, lists Apple, Microsoft and Broadcom among its largest holdings, highlighting different construction outcomes across dividend funds.
That difference traces to SCHD’s index rules. The Dow Jones U.S. Dividend 100 Index screens for companies with at least 10 consecutive years of dividend increases and for balance-sheet strength. The result is an income-focused ETF designed to reward dividend growth, but the screening and weighting approach can produce concentrated positions despite a 100-stock roster.
Sector tilts amplify the concentration issue. After the March 2026 reconstitution, energy fell from 24% to roughly 16% of the fund, while healthcare sits at about 18%. Those shifts show the portfolio can move materially at annual reconstitution, yet even with energy trimmed the top-10 share remains above the S&P 500’s top-10 concentration of 36%.
The practical consequence is straightforward: investors treating SCHD as a one‑ticker substitute for broad dividend exposure may be underestimating single-stock and sector risk. For the 63‑year‑old retiree with a $400,000 position in SCHD, roughly $164,000 is concentrated in ten stocks today—an outcome that matters if any of those names or their sectors stumble.
SCHD reconstitutes its index once a year in March, which is the mechanism that can reduce or increase concentration. The March rebalance already trimmed energy this year, demonstrating that annual changes can alter sector weightings, but the precise composition and weights of the top 10 at the next reconstitution are not settled until the index adjustment is published.
The single most consequential unanswered question for SCHD holders is whether the next March reconstitution will materially lower the ETF’s 41% top‑10 concentration and, if not, whether investors should pair SCHD with broader, lower‑concentration dividend or core equity exposures to manage the concentrated risk.
